PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Chart, page-3467

  1. 193 Posts.
    lightbulb Created with Sketch. 140
    yes fair point re want people ultimately want.

    my view is that yes we have waited forever and whilst I agree people want what u suggest, I am hopeful the cumulative effect of what I mentioned moves the needle.

    asx 300 inclusion is just maths. index funds need to buy 9% of our stock. that will make a difference. then if we do get a deal etc and it really moves, then Asx 200 is a whole lot more.

    and I hear the peer review paper is crucial for USA domiciled biotech funds.

    let's see what the next few months brings.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.